Adults seeking metabolic support during weight loss may benefit after provider review
Statements Author contributions YW: Conceptualization, Investigation, Resources, Writing original draft, Funding acquisition, Writing review & editing, Project administration, Data curation, Formal analysis, Methodology
A trial of more than 17,000 people found semaglutide (the active drug in Ozempic/Wegovy) cut the risk of serious heart attacks and strokes by 20%, even in people without diabetes
It calls for a different response from the FDA. Regulation recommendations The APC is pushing for adding the seven injectable peptides to the FDAs 503A Bulk Drug Substances List, but calls for supply chain fixes first
(PubMed) Gross CJ, Henderson LM, Savaiano DA
This guide explores the current scientific interest surrounding BPC-157, including handling considerations, peptide properties, and research-focused applications